Section one: Contracting authority/entity
one.1) Name and addresses
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
10 South Colonnade
London
E14 4PU
Contact
Commercial Operations
procurementnotices@ukhsa.gov.uk
Country
United Kingdom
Region code
UKI42 - Tower Hamlets
Internet address(es)
Main address
https://www.gov.uk/government/organisations/uk-health-security-agency
Buyer's address
https://www.gov.uk/government/organisations/uk-health-security-agency
one.6) Main activity
Other activity
Health Security
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Primary human cells for Organ-on-chip studies
two.1.2) Main CPV code
- 33696500 - Laboratory reagents
two.1.3) Type of contract
Supplies
two.1.4) Short description
This VEAT notice indicates that the UK Health Security Agency (UKHSA) intends to directly award a contract to Lonza Group UK Ltd for the purchase of HLA-typed human small airway epithelial cells (SAEC), lung microvascular endothelial cells (HMVEC-L), and human immune cells (PBMC) over a three-year period.
two.1.6) Information about lots
This contract is divided into lots: No
two.2) Description
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
Main site or place of performance
UKHSA Porton Down
Manor Farm Road
Salisbury
SP4 0JG
two.2.4) Description of the procurement
UKHSA requires to purchase HLA typed matching human small airway epithelial cells (SAEC), lung microvascular endothelial cells (HMVEC-L) and human immune cells (PMBC) over a 3-year period. Cells will be used in an established human Lung on a Chip (LoC) system at Porton Down. In order that LoC platforms can generate the most representative models of human organs, cells harvested directly from recently deceased, healthy humans are required (primary human cells). UKHSA believes that the only supplier that has a large enough clinical network underpinning their catalogue to maximise availability of donors to UKHSA (and the critical donor information including HLA type) is Lonza Group. Supply of these specific cells are limited. While suppliers/re-sellers of some cell types could be found, the requirement for having SAEC and MVEC from the same donor along with a large bank of Peripheral blood mononuclear cells (PBMC) donors in order to maximise compatibility excluded the majority of the small operations and re-sellers. Therefore, a decision has been made to enter into a 3-year agreement with Lonza Group for this procurement with 12-month extension option available.
two.2.11) Information about options
Options: Yes
Description of options
12 month contract extension option available.
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Award of a contract without prior publication of a call for competition in the cases listed below
- The procurement falls outside the scope of application of the regulations
Explanation:
Competition is absent for technical reasons.
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes
Section five. Award of contract/concession
A contract/lot is awarded: Yes
five.2) Award of contract/concession
five.2.1) Date of conclusion of the contract
4 July 2024
Section six. Complementary information
six.4) Procedures for review
six.4.1) Review body
High Court and Court of Appeal of England and Wales
Strand
London
WC2A 2LL
internationalrelationsrudicialoffice@judiciary.uk
Country
United Kingdom